Annual Working Capital
$382.02 M
+$212.71 M+125.64%
December 31, 2024
Summary
- As of February 28, 2025, SMMT annual working capital is $382.02 million, with the most recent change of +$212.71 million (+125.64%) on December 31, 2024.
- During the last 3 years, SMMT annual working capital has risen by +$310.33 million (+432.89%).
- SMMT annual working capital is now -38.18% below its all-time high of $617.93 million, reached on December 31, 2022.
Performance
SMMT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$382.02 M
-$49.26 M-11.42%
December 31, 2024
Summary
- As of February 28, 2025, SMMT quarterly working capital is $382.02 million, with the most recent change of -$49.26 million (-11.42%) on December 31, 2024.
- Over the past year, SMMT quarterly working capital has increased by +$242.19 million (+173.21%).
- SMMT quarterly working capital is now -38.18% below its all-time high of $617.93 million, reached on December 31, 2022.
Performance
SMMT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SMMT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +125.6% | +173.2% |
| 3 y3 years | +432.9% | +65.7% |
| 5 y5 years | +480.0% | +560.4% |
SMMT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.2% | +432.9% | -38.2% | +494.8% |
| 5 y | 5-year | -38.2% | +480.0% | -38.2% | +1528.4% |
| alltime | all time | -38.2% | >+9999.0% | -38.2% | >+9999.0% |
Summit Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $382.02 M(+125.6%) | $382.02 M(-11.4%) |
| Sep 2024 | - | $431.28 M(+128.6%) |
| Jun 2024 | - | $188.63 M(+34.9%) |
| Mar 2024 | - | $139.83 M(-17.4%) |
| Dec 2023 | $169.31 M(-72.6%) | $169.31 M(+85.6%) |
| Sep 2023 | - | $91.21 M(-57.7%) |
| Jun 2023 | - | $215.57 M(-6.5%) |
| Mar 2023 | - | $230.58 M(-62.7%) |
| Dec 2022 | $617.93 M(+762.0%) | $617.93 M(+413.1%) |
| Sep 2022 | - | $120.44 M(+87.5%) |
| Jun 2022 | - | $64.22 M(-16.3%) |
| Mar 2022 | - | $76.71 M(+7.0%) |
| Dec 2021 | $71.69 M(+5.8%) | $71.69 M(-9.7%) |
| Sep 2021 | - | $79.42 M(-20.3%) |
| Jun 2021 | - | $99.59 M(+90.9%) |
| Mar 2021 | - | $52.16 M(-23.0%) |
| Dec 2020 | $67.78 M(+2.9%) | - |
| Dec 2020 | - | $67.78 M(+148.0%) |
| Sep 2020 | - | $27.34 M(-52.7%) |
| Mar 2020 | - | $57.84 M(+146.6%) |
| Dec 2019 | $65.86 M(+49.5%) | - |
| Oct 2019 | - | $23.46 M(-22.4%) |
| Jul 2019 | - | $30.25 M(-21.7%) |
| Apr 2019 | - | $38.61 M(-12.3%) |
| Jan 2019 | $44.05 M(+142.0%) | - |
| Jan 2019 | - | $44.05 M(+80.4%) |
| Oct 2018 | - | $24.41 M(-23.0%) |
| Jul 2018 | - | $31.70 M(+10.5%) |
| Apr 2018 | - | $28.69 M(+57.6%) |
| Jan 2018 | $18.20 M(-35.1%) | - |
| Jan 2018 | - | $18.20 M(-58.5%) |
| Oct 2017 | - | $43.84 M(+27.9%) |
| Jul 2017 | - | $34.28 M(+64.2%) |
| Apr 2017 | - | $20.88 M(-25.6%) |
| Jan 2017 | $28.05 M(+11.7%) | - |
| Jan 2017 | - | $28.05 M(-19.8%) |
| Oct 2016 | - | $34.96 M(+273.2%) |
| Jul 2016 | - | $9.37 M(-50.1%) |
| Apr 2016 | - | $18.79 M |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2016 | $25.11 M(+43.4%) | - |
| Jan 2016 | - | $25.11 M(-27.2%) |
| Oct 2015 | - | $34.49 M(-17.1%) |
| Jul 2015 | - | $41.62 M(-11.0%) |
| Apr 2015 | - | $46.78 M(+167.1%) |
| Jan 2015 | $17.51 M(+766.0%) | - |
| Jan 2015 | - | $17.51 M(-22.5%) |
| Oct 2014 | - | $22.60 M(-18.8%) |
| Jul 2014 | - | $27.84 M(+1276.5%) |
| Jan 2014 | $2.02 M(-51.8%) | - |
| Jan 2014 | - | $2.02 M(-73.7%) |
| Jul 2013 | - | $7.69 M(+83.3%) |
| Jan 2013 | $4.20 M(+96.8%) | - |
| Jan 2013 | - | $4.20 M(-40.0%) |
| Jul 2012 | - | $7.00 M(+228.3%) |
| Jan 2012 | $2.13 M(-46.6%) | - |
| Jan 2012 | - | $2.13 M(-46.6%) |
| Jul 2011 | - | $3.99 M(+0.0%) |
| Jan 2011 | $3.99 M(-54.8%) | - |
| Jan 2011 | - | $3.99 M(-36.6%) |
| Jul 2010 | - | $6.30 M(-28.7%) |
| Jan 2010 | $8.83 M(+73.1%) | - |
| Jan 2010 | - | $8.83 M(+103.6%) |
| Jul 2009 | - | $4.34 M(-15.0%) |
| Jan 2009 | $5.10 M(-72.4%) | - |
| Jan 2009 | - | $5.10 M(-67.3%) |
| Jul 2008 | - | $15.62 M(-15.6%) |
| Jan 2008 | $18.52 M(-48.0%) | - |
| Jan 2008 | - | $18.51 M(-41.2%) |
| Jul 2007 | - | $31.47 M(-11.6%) |
| Jan 2007 | $35.59 M(+59.6%) | - |
| Jan 2007 | - | $35.59 M(-8.2%) |
| Jul 2006 | - | $38.79 M(+73.9%) |
| Jan 2006 | $22.31 M(-15.8%) | - |
| Jan 2006 | - | $22.31 M(-0.6%) |
| Jul 2005 | - | $22.45 M(-15.3%) |
| Jan 2005 | $26.49 M | - |
| Jan 2005 | - | $26.49 M(<-9900.0%) |
| Jul 2004 | - | -$32.80 K |
FAQ
- What is Summit Therapeutics annual working capital?
- What is the all time high annual working capital for Summit Therapeutics?
- What is Summit Therapeutics annual working capital year-on-year change?
- What is Summit Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Summit Therapeutics?
- What is Summit Therapeutics quarterly working capital year-on-year change?
What is Summit Therapeutics annual working capital?
The current annual working capital of SMMT is $382.02 M
What is the all time high annual working capital for Summit Therapeutics?
Summit Therapeutics all-time high annual working capital is $617.93 M
What is Summit Therapeutics annual working capital year-on-year change?
Over the past year, SMMT annual working capital has changed by +$212.71 M (+125.64%)
What is Summit Therapeutics quarterly working capital?
The current quarterly working capital of SMMT is $382.02 M
What is the all time high quarterly working capital for Summit Therapeutics?
Summit Therapeutics all-time high quarterly working capital is $617.93 M
What is Summit Therapeutics quarterly working capital year-on-year change?
Over the past year, SMMT quarterly working capital has changed by +$242.19 M (+173.21%)